August 27, 2016 12:48 AM ET

Biotechnology

Company Overview of Eleven Biotherapeutics, Inc.

Executive Profile

Gregory L. Verdine Ph.D.

AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 12 different industries.

See Board Relationships
57--

Background

Dr. Gregory L. Verdine, also known as Greg, Ph.D., serves as the Chief Executive Officer and President of FOG Pharmaceuticals. Dr. Verdine is a Co-Founder of Warp Drive Bio, LLC and serves as its Chairman of The Scientific Advisory Board. Dr. Verdine is the founder of Verdyne Partners LLC and serves as its President and Chief Executive Officer. He is a Co-Founder at Eleven Biotherapeutics Inc and Tokai Therapeutics. He is the President and Director at Fog Pharmaceuticals, ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-871-9911
Fax: 617-858-0911

Board Members Memberships

Co-Founder, Chairman of the Scientific Advisory Board and Director
President and Director
2012-Present
Chairman

Education

PhD
Columbia University
Unknown/Other Education
Massachusetts Institute of Technology
BS
Saint Joseph's University
Unknown/Other Education
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eleven Biotherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.